http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Breast architecture and the pathogenesis of cancer -- The enzymatic systems in the formation and transformation of estrogens in normal and cancerous human breast : control and potential clinical applications -- Pregnancy and breast cancer -- The cellular origins of breast cancer subtypes -- The importance of estrogen receptors in breast cancer -- Progesterone receptor isoforms and human breast cancer -- Compensatory signalling promoted by antihormones and anti-growth factor therapies in breast cancer : a starting point for the development of resistance to targeted treatment -- Apoptosis, cell death and breast cancer -- Aromatase inhibitors and their application to the treatment of breast cancer -- Aromatase inhibition in breast cancer : update of clinical applications -- Testosterone, other androgens and breast cancer -- Combination of breast cancer prevention with tissue-targeted hormone replacement therapy -- Practical progress in the chemoprevention of breast cancer with selective estrogen receptor modulators -- Oncostatic effect of analogs of LHRH on breast cancer -- Vitamin D and breast cancer --
Insulin-like growth factor signaling in normal mammary gland development and breast cancer progression -- Insulin-like growth factor-I and breast cancer : epidemiological and clinical data -- Proliferation of breast cells by steroid hormones and their metabolites -- Lignans and breast cancer -- Breast cancer risk, soyfood intake and isoflavone exposure : a review of the in vitro, animal, epidemiologic, and clinical literature -- Body size and breast cancer -- Antiangiogenic therapy of breast cancer : rationale and clinical results -- Cytotoxic therapy and other nonhormonal approaches for the treatment of metastatic breast cancer -- Adjuvant and neoadjuvant systemic chemotherapy and biologic therapy for operable and locally advanced breast cancer -- BRCA1, BRCA2, and hereditary breast cancer.
Includes bibliographical references and index.